glp 1 schizophrenia In non-obese patients with schizophrenia, antipsychotic-related diabetes may not be about weight at all. A letter in JCP responding to McIntyre's -1 commentary proposes a β-cell–centric view — especially for Asian populations — Figure 1 from Glucagon-like peptide-1

Program highlight: The session Obstructive Sleep Apnea and Cardiovascular Disease VSSMVNHA Consensus, which aims to promote interdisciplinary collaboration between Cardiology, Pulmonology, and Sleep Medicine in the screening, diagnosis, and management of sleep apnea in cardiovascular patients

A GLP-1 Vision Loss Lawsuit is a legal claim filed by individuals who have experienced sudden or permanent vision loss, such as non-arteritic anterior ischemic optic neuropathy (NAION), after using GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound

In the 24-week study of patients receiving JANUVIA as add-on therapy to insulin (with or without metformin), there were no adverse reactions reported regardless of investigator assessment of causality in 5% of patients and more commonly than in patients given placebo, except for hypoglycemia (see Table 3)

Therefore, semaglutide exerts effects beyond merely reducing food intake [56]

J Int AIDS Soc 20(1):21526 Villoslada-Blanco P et al (2022) Integrase inhibitors partially restore bacterial translocation, inflammation and gut permeability induced by HIV infection: impact on gut microbiota